Literature DB >> 16240439

Complexation with chondroitin sulfate C and Polybrene rapidly purifies retrovirus from inhibitors of transduction and substantially enhances gene transfer.

Natalia Landázuri1, Joseph M Le Doux.   

Abstract

Using amphotropic retrovirus stocks produced by TELCeB6-A cells that encode the Escherichia coli lacZ gene, we found that complexation with chondroitin sulfate C (CSC) and Polybrene (PB) is an effective means to purify retrovirus. Virus stocks contained high levels of inhibitory activity that blocked amphotropic, but not ecotropic, retrovirus transduction. When virus stocks were brought to 80 microg/mL each of CSC and PB, complexes of CSC and PB formed. These complexes incorporated more than 70% of the virus particles but less than 0.4% of all other proteins and no detectable inhibitory activity. Purified virus transduced NIH 3T3 murine fibroblasts 21 to 186-fold more efficiently than virus that was not purified. In addition, virus purification significantly altered the dose response of transduction. When virus that had not been purified was used to transduce cells, the relationship between transduction and virus concentration was highly non-linear. In contrast, when purified virus was used, transduction increased monotonically and was linearly proportional to virus concentration, except when high doses of virus were used. Interestingly, when high doses of virus were used gene transfer reached a maximum plateau level, most likely because particle-associated amphotropic envelope proteins had saturated the cellular receptors for the virus. Our findings illustrate that retrovirus purification increases the maximum number of genes that can be transferred, reduces the amount of virus required to achieve a given level of gene transfer, and reduces uncertainties about the relationship between the amount of virus used and the number of genes transferred.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16240439     DOI: 10.1002/bit.20697

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  7 in total

1.  Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response.

Authors:  Marie Bénéteau; Barbara Zunino; Marie A Jacquin; Ophélie Meynet; Johanna Chiche; Ludivine A Pradelli; Sandrine Marchetti; Aurore Cornille; Michel Carles; Jean-Ehrland Ricci
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

2.  Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexes.

Authors:  Mickaël Marloye; Haider Inam; Connor J Moore; Vinciane Debaille; Justin R Pritchard; Michel Gelbcke; Franck Meyer; François Dufrasne; Gilles Berger
Journal:  J Biol Inorg Chem       Date:  2021-06-26       Impact factor: 3.358

3.  A new chemical complex can rapidly concentrate lentivirus and significantly enhance gene transduction.

Authors:  Jing-Yu Lee; Hu-Hui Lee
Journal:  Cytotechnology       Date:  2017-09-07       Impact factor: 2.058

4.  Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes.

Authors:  Mauro Pistello; Laura Vannucci; Alessia Ravani; Francesca Bonci; Flavia Chiuppesi; Barbara del Santo; Giulia Freer; Mauro Bendinelli
Journal:  Genet Vaccines Ther       Date:  2007-09-19

5.  Rat macrophage C-type lectin is an activating receptor expressed by phagocytic cells.

Authors:  Ana Lobato-Pascual; Per Christian Saether; Maria K Dahle; Peter Gaustad; Erik Dissen; Sigbjørn Fossum; Michael R Daws
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

6.  Improved coinfection with amphotropic pseudotyped retroviral vectors.

Authors:  Yuehong Wu; David W Melton; Yong Zhang; Peter J Hornsby
Journal:  J Biomed Biotechnol       Date:  2009-05-25

7.  Lentiviral vector transduction of spermatozoa as a tool for the study of early development.

Authors:  Anil Chandrashekran; Ihsan Isa; Jayesh Dudhia; Adrian J Thrasher; Nicholas Dibb; Colin Casimir; Carol Readhead; Robert Winston
Journal:  FEBS Open Bio       Date:  2014-03-03       Impact factor: 2.693

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.